Concepedia

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial

Joost H. C. M. Kreijtz, Marco Goeijenbier, Fleur M. Moesker, L. Van den Dries, Simone Goeijenbier, Heidi L. M. De Gruyter, Michael H. Lehmann, Gerrie de Mutsert, David van de Vijver, Asisa Volz,

The Lancet Infectious Diseases · 2014 · 93 citations · 22 references

DOI

Concepts

References

22

Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets

Sander Herfst, Eefje J. A. Schrauwen, Martin Linster et al. · Science · 2012 · 1.7K citations · Full text

, , +17

Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1

Tamara Berthoud, Matthew M. Hamill, Patrick Lillie et al. · Clinical Infectious Diseases · 2010 · 382 citations · Full text

, , +17

Identification, Characterization, and Natural Selection of Mutations Driving Airborne Transmission of A/H5N1 Virus

Martin Linster, Sander van Boheemen, Miranda de Graaf et al. · Cell · 2014 · 315 citations · Full text

, , +16

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

Grazia Galli, Kathy Hancock, Katja Höschler et al. · Proceedings of the National Academy of Sciences · 2009 · 261 citations · Full text

, , +17

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

Patrick Lillie, Tamara Berthoud, Timothy J. Powell et al. · Clinical Infectious Diseases · 2012 · 249 citations · Full text

, , +17